Raia Drogasil S.A.
RADLY
$5.00
$0.000.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.80B | 1.78B | 1.70B | 1.53B | 1.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.80B | 1.78B | 1.70B | 1.53B | 1.49B |
| Cost of Revenue | 1.26B | 1.25B | 1.18B | 1.08B | 1.04B |
| Gross Profit | 542.56M | 531.05M | 527.10M | 446.83M | 449.56M |
| SG&A Expenses | 446.40M | 430.79M | 401.81M | 364.23M | 356.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.31M | -9.38M | 121.20K | -430.30K | 2.48M |
| Total Operating Expenses | 1.70B | 1.67B | 1.58B | 1.44B | 1.40B |
| Operating Income | 99.47M | 109.63M | 125.17M | 83.03M | 90.77M |
| Income Before Tax | 59.64M | 61.88M | 84.08M | 39.17M | 55.72M |
| Income Tax Expenses | 3.45M | 6.90M | 14.80M | 1.06M | 989.80K |
| Earnings from Continuing Operations | 56.18M | 54.98M | 69.28M | 38.11M | 54.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.48M | -914.40K | -988.10K | -1.11M | -450.50K |
| Net Income | 52.70M | 54.06M | 68.30M | 37.00M | 54.28M |
| EBIT | 99.47M | 109.63M | 125.17M | 83.03M | 90.77M |
| EBITDA | 133.13M | 143.49M | 158.17M | 113.37M | 121.24M |
| EPS Basic | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 |
| EPS Diluted | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 1.72B | 1.69B | 1.74B | 1.71B | 1.71B |
| Average Diluted Shares Outstanding | 1.72B | 1.69B | 1.74B | 1.75B | 1.72B |
| Dividend Per Share | 0.04 | -- | 0.01 | 0.01 | -- |
| Payout Ratio | 91.65% | 0.11% | 66.98% | 0.01% | 79.88% |
